MediFind
Condition

Transverse Myelitis

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorders
  • Journal: Scientific reports
  • Treatment Used: Mycophenolate Mofetil Therapy
  • Number of Patients: 1047
  • Published —
The study researched the outcomes of mycophenolate mofetil therapy for patients with neuromyelitis optica spectrum disorders.
Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD) During the COVID-19 Pandemic
  • Journal: Therapeutics and clinical risk management
  • Treatment Used: Disease-Modifying Therapies (DMTs)
  • Number of Patients: 0
  • Published —
This study examined neuromyelitis optica spectrum disorder (NMOSD) disease-modifying therapies (DMTs) during the COVID-19 pandemic.
Latest Advance
Study
  • Condition: Dual Spinal Cord Injury with Transverse Myelitis
  • Journal: Spinal cord series and cases
  • Treatment Used: Clinical Management
  • Number of Patients: 1
  • Published —
This case report describes a patient with a dual spinal cord injury that later contracted transverse myelitis.
Latest Advance
Study
  • Condition: Recurrent Optic Neuritis Associated with Aquaporin (AQP) 4 Antibody Seropositive Neuromyelitis Optica (NMO-ON)
  • Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • Treatment Used: Intravenous Methylprednisolone Pulse (IVMP) Therapy
  • Number of Patients: 35
  • Published —
This study observed the effects of intravenous methylprednisolone pulse (IVMP) therapy on the recovery of visual acuity and its influencing factors in patients with the relapse of aquaporin (AQP) 4 antibody positive neuromyelitis optica related optic neuritis (NMO-ON).
Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorder
  • Journal: Neurology(R) neuroimmunology & neuroinflammation
  • Treatment Used: Inhibition of IL-6 Activity
  • Number of Patients: 0
  • Published —
The study researched the outcomes of inhibition of IL-6 activity in patients with neuromyelitis optica spectrum disorder.
Latest Advance
Study
  • Condition: Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
  • Journal: Scientific reports
  • Treatment Used: Disease Modifying Drugs
  • Number of Patients: 62
  • Published —
The study researched patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders.
Latest Advance
Study
  • Condition: Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
  • Journal: Neurology(R) neuroimmunology & neuroinflammation
  • Treatment Used: Disease-Modifying Therapy
  • Number of Patients: 67
  • Published —
This study tested the safety and efficacy of using azathioprine, mycophenolate mofetil, or rituximab to treat patients with aquaporin-4 antibody-positive NMOSD.
Latest Advance
Study
  • Condition: Central Nervous System Demyelinating Diseases During the Coronavirus Disease 2019 Pandemic
  • Journal: Arquivos de neuro-psiquiatria
  • Treatment Used: Management Strategies
  • Number of Patients: 0
  • Published —
This article discusses management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic.
Latest Advance
Study
  • Condition: Encephalomyeloneuritis and Arthritis
  • Journal: Neurology(R) neuroimmunology & neuroinflammation
  • Treatment Used: Anti-PD-L1 Inhibitors
  • Number of Patients: 1
  • Published —
This case report describes a patient with encephalomyeloneuritis and arthritis that was treated using anti-PD-L1 inhibitors such as nivolumab and ipilimumab.
Latest Advance
Study
  • Condition: Neuromyelitis Optica
  • Journal: Neurology
  • Treatment Used: Scrambler Therapy
  • Number of Patients: 22
  • Published —
The study researched the use of scrambler therapy in treating neuromyelitis optica.
Latest Advance
Study
  • Condition: Pneumocystis jirovecii Pneumonia
  • Journal: The Tohoku journal of experimental medicine
  • Treatment Used: Veno-Venous Extracorporeal Membrane Oxygenation
  • Number of Patients: 1
  • Published —
The study reported a case of pneumocystis jirovecii pneumonia treated with veno-venous extracorporeal membrane oxygenation.
Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)
  • Journal: Neurology
  • Treatment Used: Immunosuppressive Agents as Early First-Line Therapy
  • Number of Patients: 136
  • Published —
This study compared the effectiveness and the risk of severe infectious events of immunosuppressive agents used early as first-line therapy in patients with neuromyelitis optica spectrum disorder (NMOSD).